Breastcancer.org Podcast

Krista Curley was diagnosed 3 1/2 years ago with estrogen-receptor-positive metastatic breast cancer in her lymph system and bones at the age of 39. She had no previous diagnosis of cancer. Since her initial diagnosis, the cancer has spread further into her bones and to her liver, despite surgery, various hormonal therapies, and chemotherapy. Krista lives in Ontario, Canada and is married to Patrick, the love of her life. She is the mother of Ethan, who is 16, and Naomi, who is 10. She has a blog about living with metastatic disease called “Metastatic Breast Cancer: Now What?”Listen to the podcast to hear Krista talk about: what writing the blog gives to her how she and her family find joy and humor in day-to-day life how she talked to her kids about metastatic disease the one thing she would tell people about metastatic breast cancer Running time: 25:20

Dr. Frank DellaCroce, or "Dr. D" as he has come to be known, is a founding partner of the Center for Restorative Breast Surgery and St. Charles Surgical Hospital in New Orleans. Board-certified in plastic surgery, Dr. D has performed thousands of reconstructive procedures, both for women diagnosed with breast cancer and women at high risk of the disease who choose to have prophylactic breast removal. He is a fellow of the American College of Surgeons and a member of numerous professional societies, including the American Society of Plastic and Reconstructive Surgery, the American Society for Reconstructive Microsurgery, and the World Society for Reconstructive Microsurgery. He also has been named one of the “Best Doctors in America.”Listen to the podcast to hear Dr. D discuss: the benefits and risks of nipple reconstruction the timing of nipple reconstruction how nipple reconstruction has evolved over the years how long the procedure takes and what recovery is like Running time: 18:06

Beth Baughman DuPree performs breast cancer surgery and is vice president at the Holy Redeemer Health System, as well as an adjunct assistant professor of surgery at the University of Pennsylvania. She is a board certified general surgeon specializing in diseases of the breast. She also has obtained dual board certification in integrative and holistic medicine. She has won numerous awards for her medical work as well as her humanitarian endeavors. Dr. DuPree’s skin-sparing mastectomies, performed in conjunction with plastic surgeon Robert Skalicky, were featured live on the Internet; the webcast and subsequent documentary received a Gracie Award. Listen to the podcast to hear Dr. DuPree discuss: the types of medicines used to control pain during breast cancer surgery non-opioid pain control options for people in recovery or who simply don’t want an opioid the side effects of pain medications ways to control pain that don’t involve medication Running time: 23:11These podcasts, along with all the other vital c

Teva Harrison is an artist, writer, and cartoonist who was diagnosed with stage IV breast cancer at age 37. She is the author of the bestselling, critically acclaimed graphic memoir, In-Between Days; the book was shortlisted for the Governor General's Literary Award for Non-Fiction. Teva is a Canadian Magazine Award and National Magazine Award finalist whose writing and/or comics have appeared in The Walrus, Quill & Quire, Huffington Post, Carte Blanche, The Humber Literary Review, The Globe and Mail, and more. She is a regular commentator on radio, television, and in newspapers, including CBC Radio, the Toronto Star, The Globe and Mail, and The Agenda with Steve Paikin. Born and raised in rural Oregon, Teva currently lives in Toronto with her husband. Listen to the podcast to hear Teva talk about: how she changed her mind about being public about her diagnosis how she controls her fear and finds joy and beauty in her life the things she’s saying yes to and how they are making her happy what leaving a lega

Suze Orman has been called “a force in the world of personal finance” and a “one-woman financial advice powerhouse” by USA Today. A two-time Emmy Award-winning television host, New York Times mega bestselling author, magazine and online columnist, writer/producer, and one of the top motivational speakers in the world today, Orman is undeniably America’s most recognized expert on personal finance.Listen to the podcast to hear Suze discuss: the four documents that EVERYONE should have what a young parent with metastatic disease can do protect the financial future of her minor children when to start taking disability or Social Security payments if you’ve been diagnosed with stage IV breast cancer the differences between wills and trusts Running time: 30:44

Several studies have shown that cooling the scalp to a very low temperature can help reduce hair loss due to chemotherapy treatment for breast cancer. In this podcast, Julie Nangia, M.D., assistant professor of medicine, Baylor College of Medicine talks about the study results she presented at the 2016 San Antonio Breast Cancer Symposium on the Orbis Paxman Hair Loss Prevention System. The study was the first prospective, randomized trial on a scalp cooling system and found that about 50% of the women who used the cooling system kept most of their hair. Listen to the podcast to hear Dr. Nangia explain: how the Paxman Hair Loss Preservation System works how the type of chemotherapy regimen the women were on affected the results why doing a prospective, randomized trial was important Running time: 9:54Editor’s Note: On April 19, 2017, the Paxman Scalp Cooling System received U.S. Food and Drug Administration clearance. This means the system can be marketed in the United States.

Dr. Philip Lammers, a medical oncologist, is the chief of the Division of Hematology/Oncology at Meharry Medical College and adjunct assistant professor of internal medicine at Vanderbilt University. He has several active research projects on ways to increase minority and underserved population representation in clinical trials. He also studies state-of-the art cancer treatments, including biosimilars.Listen to the podcast to hear Dr. Lammers explain: what a biosimilar drug is, as well as the approval process for biosimilars how we can be sure that biosimilars are as safe as the reference products the advantages and disadvantages of biosimilars when we might see biosimilars on the market to treat breast cancer Running time: 15:10

Sage Bolte is executive director of Life With Cancer and also serves as associate director of psychosocial program for the Inova Health System. She is an internationally recognized educator and speaker on sexual health, intimacy, and relationships among people diagnosed with cancer and other chronic diseases. She conducts lectures, workshops, and training to both patient and healthcare professional groups on the topic of the sexual self and cancer survivorship. Her goal is to help empower patients to reclaim their sexual selves in spite of the many physical and emotional changes they may experience from their cancer diagnosis and to help healthcare professionals feel more comfortable and knowledgeable to assess and address the sexual health needs of their patients.Listen to the podcast to hear Sage talk about: how women diagnosed with metastatic disease can redefine sexual health so they’re fulfilled and satisfied tips for women who are having vaginal pain/dryness, including stretching and strengthening exerc

Leah Eshraghi, director of clinical research at the Dr. Susan Love Research Foundation, discusses the poster she presented on quality of life and disease collateral damage in women diagnosed with metastatic breast cancer. Running time: 3:05

Breastcancer.org Chief Medical Officer and Founder Marisa Weiss, M.D. talks how radiation therapy can affect different types of breast reconstruction. Running time: 4:28

Breastcancer.org Chief Medical Officer and Founder Marisa Weiss, M.D. talks about the importance of sticking with a hormonal therapy treatment plan and ways to deal with any side effects. Running time: 1:50

Breastcancer.org Chief Medical Officer and Founder Marisa Weiss, M.D. offers her take on a new device that may help women keep quite a bit of their hair during chemotherapy. Running time: 2:11

The experimental medicine buparlisib helps treat metastatic hormone-receptor-positive, HER2-negative breast cancer that has been treated with an aromatase inhibitor, but grew after being treated with Afinitor (chemical name: everolimus) and Aromasin (chemical name: exemestane). In this podcast from the 2016 San Antonio Breast Cancer Symposium, Ruth O'Regan, M.D., professor of hematology and oncology at the University of Wisconsin and one of the researchers who did the phase III BELLE-3 trial, discusses the results of the study and explains why the mechanics of how buparlisib work are promising, even if buparlisib probably isn't the right medicine to treat breast cancer.Listen to the podcast to hear Dr. O'Regan talk about: how buparlisib works why inhibiting the PI3 kinase pathway may help treat metastatic, hormone-receptor-positive disease that has stopped responding to hormonal therapy buparlisib's unacceptable side effects how she plans to talk to her patients about buparlisib Running time: 5:04

"An exciting but early time."Oncologist Philomena McAndrew talks about the exciting, but still early research on what's called by a variety of names: liquid tumor biopsies, circulating tumor cells, and cell free DNA and what the development of these tests might mean for patients in the future. Running time: 1:59

"I've been on a roll of male breast cancer advocacy."Breast cancer survivor Michael Singer was staffing the Male Breast Cancer Coalition booth at the 2016 San Antonio Breast Cancer Symposium. In this mini podcast, he talks about his diagnosis and how he works to raise awareness that men can be breast cancer patients, too. Running time: 3:27

In August 2016, Stephen Sala found a small lump on the right side of his chest. His doctor thought it was a cyst, but scheduled an ultrasound to be sure. His ultrasound results were concerning, so he had a mammogram the same day, followed a needle biopsy about a week later. The results showed breast cancer. He was 41. He decided to have a bilateral mastectomy to reduce his risk of contralateral disease; pathology results showed that he had cancer in his left chest as well. As he went through diagnosis and treatment, Steve experienced a number of awkward situations. Almost all mammography offices are in women’s health care centers, with no consideration for men. Forms asked when he had his last period, how many children he had given birth to, and if he was in menopause.Listen to the podcast to hear Stephen talk about: how he came to terms with a breast cancer diagnosis his ideas on how the process can be made less clumsy for men how he talked to his children about his diagnosis how he found support advice he w

In our premiere podcast, we're excited to bring you a summary of the day's research highlights from the San Antonio Breast Cancer Symposium 2013! We discuss treatments before surgery for HER2-positive cancers, radiation after lumpectomy in women over age 65, and more. Breastcancer.org medical adviser Brian Wojciechowski, M.D. and senior editor Jamie DePolo explain the latest news.Running time: 26:14These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

Listen to the December 12 updates from the 2013 San Antonio Breast Cancer Symposium on today's podcast! In this edition, we fill you in on the latest research about Arimidex (chemical name: anastrazole) for reducing the risk of a primary breast cancer, sticking to your aromatase inhibitor regimen, strength training and aerobics for the relief of aromatase inhibitor-induced joint pain relief, and survival improvements with bisphosphonates after early breast cancer. Breastcancer.org medical adviser Brian Wojciechowski, M.D. and senior editor Jamie DePolo explain the latest news.Running time: 27:16 These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.

In this edition of our podcast coverage from the 2013 San Antonio Breast Cancer Symposium, we bring you the latest information from these areas of breast cancer research: post-treatment psychosocial and physical issues updates on chemotherapy in high-risk women, early and metastatic breast cancers, triple-negative breast cancers, and in women with high numbers of circulating tumor cells a new design for clinical trials that may allow drugs to become available sooner breast cancer incidence in women using hormonal treatments for infertility a presentation on what women know about risk reduction versus how they put this knowledge into practice, from Breastcancer.org Chief Medical Officer Marisa Weiss, M.D. Running time: 24:18These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women wh

In the March 2014 Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses some of the most talked about research studies that were published in February 2014. Listen to the podcast to hear Dr. Wojciechowski explain: the Canadian mammogram study and why it’s flawed why the FDA is warning women not to use ductal lavage in place of mammograms the importance of starting chemotherapy within 30 days of surgery how yoga can ease fatigue and reduce inflammation in women diagnosed with breast cancer how acupuncture can ease aromatase inhibitor side effects Running time: 23:01These podcasts, along with all the other vital content and community support at Breastcancer.org, only exist because of the generous donations of listeners like you. Please visit Breastcancer.org/support to learn how you can help keep our services free for you and the millions of women who depend on us.